Skip to content
Use case 141

Telemedicine Consultation Terminals

A deployment concept for health services, telehealth providers, remote clinics and aged-care organisations.

Proposed deployment · Compatibility assessment required
Healthcare and Life Sciences

Why this environment matters

Security for telemedicine consultation terminals extends beyond passwords and network firewalls. The system supports remote video, messaging, identity checks and access to clinical information, while consumer networks, shared devices or malicious links can expose consultations and patient records. NØNOS could be evaluated as an execution layer that verifies software identity, limits device access and avoids unnecessary long-lived state.

The security challenge

Healthcare systems process deeply sensitive data while supporting time-critical clinical decisions. Security must improve trust without delaying care or obscuring the human responsibility for treatment. In telemedicine consultation terminals, the decisive risk is that consumer networks, shared devices or malicious links can expose consultations and patient records. Even strong perimeter controls may not help once authorised software, a vendor tool or a valid user session has been compromised. Internal permission boundaries must remain enforceable after initial access.

How the capsule model could help

For this system, NØNOS could provide a resettable consultation capsule with isolated camera, microphone, browser and record access that ends cleanly after the appointment. The design would combine minimal sensitive persistence, attested privileged sessions, patient-context capabilities and signed clinical software. The intended result would be a set of small trust boundaries instead of one large operating environment where every service inherits broad ambient access.

Separate address spaces and capability checks can limit cross-process reach. They cannot stop harmful use of legitimate permissions, prove AI decisions correct or substitute for domain-specific safety controls.

Deployment requirements

Clinical deployment would require medical-device validation, patient-safety risk management, privacy review, human factors testing and integration with existing approved workflows. Security controls must never obstruct emergency care.

Current public-beta limitations, hardware support and application availability must be assessed before any pilot. Neither this use case nor an industry source establishes NONOS certification or a current customer deployment.

Who could buy or integrate it?

  • Telemedicine platform vendors integrating consultation terminals
  • Healthcare providers buying shared virtual-care stations
  • Managed care-technology providers deploying remote consultation equipment

Industry examples: Teladoc Health, American Well. Organisations shown illustrate the industry. No NONOS customer, partner or endorsement relationship is implied.

Market opportunity

Market benchmarks and device scenarios.

Published industry benchmark
US$130.5 billion

Telemedicine

Global · 2025 · annual market estimate

Telemedicine products and services, including consultations, monitoring and education.

Modelled global devices
100K–2M

Candidate OS endpoints

Hypothetical planning range · 2025

Low confidence: planning assumptions. Hardware compatibility, procurement and adoption have not been validated.

Illustrative annual licensing
$2.5M–$240M

USD / year at full model coverage

Device scenario × assumed US$25–$120 per device / year.

Not a revenue forecast, announced price or measured serviceable market.

Device calculation

Hypothetical global planning range, 2025 scenario: assume 100,000–500,000 clinics and care providers using dedicated telemedicine stations × 1–4 candidate OS endpoints per site/asset = 100,000–2,000,000 endpoints. Counting unit: dedicated consultation terminals; patient smartphones excluded. Site and asset counts, and devices per site, are planning assumptions. The installed base has not been measured. Coverage is limited to the defined equipped subset; includes all candidate endpoints within that assumed subset. Hardware eligibility, certification, adoption and achievable NØNOS share are unverified; overlaps other cases.

Telemedicine Market Size, Share & Trends Report 2026-2033 ↗

Market context only; separate from device and site population estimates. Original monetary-market scope and geography are preserved in benchmark. This source does not establish the assumed worldwide site count or endpoint density.

How to interpret the figures

Adjacent or broader commercial market benchmark; not the NØNOS OS market, licensable-device count or revenue forecast.

Modelled candidate endpoints multiplied by an assumed annual USD price per endpoint. Pricing is a planning assumption, not a vendor quote. This illustrates the full scenario range, not revenue or total addressable market. It excludes adoption timing, procurement, certification, support costs, channel economics and achievable market share. Use cases can overlap, so their totals do not represent unique devices.

Research from 2026. Publisher estimates have not been independently audited.

Read the full methodology

Explore NONOS

Choose your
NONOS experience.

Discover the platform for your organisation or explore the software.

You can reopen this chooser from the footer at any time.